Abstract B012: BET inhibition sensitizes preclinical models of bladder cancer to DDR inhibitors
Year: 2024
Type: conference-abstract
Source: Clinical Cancer Research
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4397012962
